Systemic Toxicity and Cytokine/Acute Phase Protein Levels in Patients After Isolated Limb Perfusion With Tumor Necrosis Factor-a Complicated by High Leakage
Tanja C. Stam(Rotterdam University of Applied Sciences), Alexander M.M. Eggermont(University Medical Center Utrecht), Mark R. de Vries(Rotterdam University of Applied Sciences), Timo L.M. ten Hagen(Erasmus MC), Anton J. G. Swaak(Rotterdam University of Applied Sciences)
Cited by 47
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k